Efficacy of lofexidine for mitigating opioid withdrawal symptoms: results from two randomized, placebo-controlled trials

Alam, D; Tirado, C; Pirner, M; Clinch, T

Alam, D (corresponding author), Northwestern Med Cent DuPage Hosp, 27W350 Highlake Rd, Winfield, IL 60190 USA.

JOURNAL OF DRUG ASSESSMENT, 2020; 9 (1): 13

Abstract

Objectives: Fear of opioid withdrawal syndrome (OWS) often dissuades opioid discontinuation. Lofexidine is an FDA-approved, alpha(2)-adrenergic recept......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索